"Hematology diagnostics market to exhibit lucrative growth during the forecast period"
The global hematology diagnostics market is Increasing blood donation procedures, rising incidences of blood disorders along with enhanced diagnostics and hematology testing technologies drives the overall hematology diagnostics market growth. New technological evolution in automated hemotology analyzers would also drive the overall market. Additionally, new standardized automated sample collection, data processing, identification & testing, and ordering of new tests among other processes will further spur revenue growth during the forecast period.
"Hematology consumables segment is expected to dominate the global market during the forecast period"
Overall sales of hematology consumables is expanding significantly on a global scale. It is anticipated to continue its dominance during the forecast period. Rising demand for consumables along with diagnosis of blood disorders and other infections will grow prominently. Moreover, increasing volume of diagnostic tests owing to growing awareness and incidence is also driving the market growth. Wide range of reagents & kits, stains, and others in the consumables segment incorporate experts to encounter the dynamic demand. The instruments segment is further distributed into analyzers, flow cytometers, and others. Increased automation which offer noble reliability, sensitivity, specificity, along with higher safety and ease of operation are estimated to be the primary growth factors driving the hematology instruments segment globally.
"The diagnostic laboratories segment is expected to register higher growth by the end of 2030"
Diagnostic laboratories in the end user segment are predicted to expand at a significant CAGR during the forecast period. The rising number of multispecialty diagnostic centers along with the availability of advanced hematology products are fueling the demand globally. Additionally, automation of diagnostic tools is anticipated to reduce the overall cost of blood testing. The rise in partnership among market players and diagnostic laboratories are factors that are likely to drive the market growth. The adoption of fully automated analyzers along with enhanced prognosis, infectious disease monitoring, diagnosis, and preliminary screening processes will drive the growth in the end user segment.
"Increasing demand for advanced equipment, and the presence of established players holds North America in dominant position"
North America to contribute maximum revenue share in the global hematology diagnostics market. Factors enhancing the growth in North America include the utilization of advanced technologies for the point of care test, rising incidences for diseases such as blood cancers, acute infectious diseases, liver and spleen diseases.
Asia Pacific is expected to grow at a significant pace owing to new technology expansion and adoption of advanced diagnostic instruments. Enhanced healthcare services along with improved government initiatives will have a positive impact on the hematology diagnostics market.
"Dominance of multinational manufacturers with strong product portfolio in the developed regions"
Major players in the hematology diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Siemens Healthineers, Mindray Medical International Limited, Danaher Corporation, Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Drew Scientific, Sysmex Corporation, EKF Diagnostics, Boule Diagnostics, HORIBA, Diatron MI Zrt. and others. Furthermore, new product launch, technology expansion to diagnostic laboratories will drive the market growth in future. Increasing prevalence of blood disorders along with other target diseases and dynamic shift from manual to automated hematology testing, and competitive benefits offered by commercial service providers in the developing nations will further assist the overall development of the market on a global scale.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Hematology Diagnostics market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Product
| |
End User
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
